LEVOTHYROXINE SODIUM Tablets Recalled Due to Subpotent Drug Content
Major Pharmaceuticals is recalling LEVOTHYROXINE SODIUM 150 mcg tablets because some batches contain less active ingredient than labeled, potentially reducing thyroid hormone effectiveness.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II recall for a subpotent drug that poses a risk of harm if taken, but no reported illnesses or injuries have been documented.
Plain-English summary
Major Pharmaceuticals is voluntarily recalling LEVOTHYROXINE SODIUM tablets, 150 mcg strength, due to the discovery that certain batches are subpotent, meaning they contain less of the active thyroid hormone ingredient than labeled. The affected products are packaged in 10-tablet unit dose blisters per carton and were distributed nationwide in the USA. The recall covers bag lot # N02167A and blister lot # N02167, both with expiration date 07/2026. Patients taking these tablets may experience reduced effectiveness of thyroid hormone replacement therapy. Consumers should not use the affected medication and should contact their healthcare provider to discuss alternative treatment options. They should return any unused medication to the pharmacy for a refund or replacement.
The recalled product
- Product
- LEVOTHYROXINE SODIUM (LEVOTHYROXINE SODIUM)
- Brand
- LEVOTHYROXINE SODIUM
- Manufacturer
- Major Pharmaceuticals
- Hazard
- subpotent-drug
- underdose
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Bag lot #: N02167A
- Exp. Date 07/2026
- Blister lot # N02167
UPCs (1)
- 0055154356305
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · LEVOTHYROXINE SODIUM
- SevereLevothyroxine Sodium Tablets Recalled for Subpotency
FDA (Drugs) · 2026-07-29
- HighLevothyroxine Sodium Tablets Recalled for Subpotency by Major Pharmaceuticals
FDA (Drugs) · 2026-07-29
- SevereLevothyroxine Sodium Tablets Recalled for Subpotency
FDA (Drugs) · 2026-07-29
- HighLevothyroxine Sodium Tablets Recalled Due to Subpotent Drug Concerns
FDA (Drugs) · 2026-07-29
- SevereMajor Pharmaceuticals Recalls Levothyroxine Sodium Tablets Over Subpotency
FDA (Drugs) · 2026-07-29
Same category
- HighRohto Cooling Eye Drops Max Strength Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-07-29
- HighNaropin Injection Recall Over Particulate Matter Contamination
FDA (Drugs) · 2026-07-29
- ModerateFDA Recalls Xylocaine Injections Due to Hair Contamination
FDA (Drugs) · 2026-07-29
- ModerateCyproheptadine Hydrochloride Syrup Recall Due to Precipitate
FDA (Drugs) · 2026-07-29
- HighLidocaine Injection Recall Due to Hair Contamination
FDA (Drugs) · 2026-07-29